Publications

Comparison of jet injector and insulin pen in type 2 diabete Hits:2018-05-25


Jinbo H, Hui S, Cahnghong Z, et al. Lispro administered by the QS-M Needle-  Free Jet Injector generates an earlier insulin exposure. Taylor & Francis. 2016;1198772.pdf


Abstract

This study is conducted to investigate efficacy of an insulin jet injector and an insulin pen in treatment of type 2 diabetic patients. Sixty patients with type 2 diabetes were treated with rapid-acting insulin (regular insulin) and insulin analog (insulin aspart) using the jet injector and the pen in 4 successive test cycles. Postprandial glucose and insulin concentrations in blood were measured over time. Areas under curves of glucose and the insulin were calculated, and efficacy of 2 injection methods in treatment of the diabetes was compared. Regular insulin and insulin aspart administration by the jet injector showed significant decreases in plasma glucose levels as compared to the pen injection (P<0.05). Postprandial plasma glucose excursions at the time points of 0.5 to 3 hours were obviously lower in the jet-treated patients than the pen-treated ones (P<0.05). Postprandial plasma insulin levels were markedly higher in the jet-treated patients than the pen-treated ones (P<0.05). Area under the glucose curve in the pen-treated patients was significantly increased as compared to the jet-treated ones (P<0.01). Efficacy of the insulin jet injector in treatment of type 2 diabetic patients is obviously superior to the insulin pen in regulating plasma glucose and insulin levels.


Please click the above link to view the full article.

Beijing time
Seoul time
London time
New York time
Sydney time
Moscow time

Copyright © 2018 TECHiJET, all rights reserved.